(2S)-6-(9H-fluoren-9-ylmethoxycarbonylamino)-2-methylhexanoic acid

• 分子结构分类: 有机化合物 - 苯类化合物 - 芴
• 英文名称: (2S)-6-(9H-fluoren-9-ylmethoxycarbonylamino)-2-methylhexanoic acid
• 化学式: C₂₂H₂₅NO₄
• 分子量: 367.4
• InChiKey: CKZUKJLVUDLVMC-HNNXBMFYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.2
• 重原子数：
  27
• 可旋转键数：
  9
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  75.6
• 氢给体数：
  2
• 氢受体数：
  4

文献信息

• Lipid-Conjugated Rhamnose for Immune System Recruitment and Oncotherapy
  申请人：WISCONSIN ALUMNI RESEARCH FOUNDATION

  公开号：US20140112975A1

  公开（公告）日：2014-04-24

  L-Rhamnose antigen-lipid conjugates for recruitment of the immune system to sites of tumor growth for initiating an anti-tumor antigen response. Methods for introducing L-rhamnose antigen-conjugated lipids into cell membranes such that L-rhamnose antigens are displayed on the cell surface. The cells can be tumor cells and more specifically can be melanoma cells. Cells are contacted with one or more L-rhamnose antigen-lipid conjugates such that L-rhamnose antigen-lipid conjugates are inserted into the cell membrane. The cells can be contacted for example by intratumoral injection. Pharmaceutical compositions containing the L-rhamnose antigen-lipid conjugates and therapeutic methods employing the conjugates and compositions.

  L-岩藻糖抗原-脂质共轭物用于招募免疫系统到肿瘤生长部位，以启动抗肿瘤抗原反应。介绍L-岩藻糖抗原共轭脂质进入细胞膜的方法，使L-岩藻糖抗原显示在细胞表面。细胞可以是肿瘤细胞，更具体地可以是黑色素瘤细胞。将细胞与一个或多个L-岩藻糖抗原-脂质共轭物接触，使L-岩藻糖抗原-脂质共轭物插入细胞膜。例如，可以通过肿瘤内注射接触细胞。含有L-岩藻糖抗原-脂质共轭物的制药组合物和使用共轭物和组合物的治疗方法。
• PROGRAMMABLE SELF-ASSEMBLED NANOSTRUCTURES BASED ON SIDECHAIN-MODIFIED PNA FOR THE MULTIVALENT DISPLAY OF LIGANDS
  申请人：Appella Daniel H.

  公开号：US20140148500A1

  公开（公告）日：2014-05-29

  The invention concerns compositions comprising strands of polynucleotide and strands of PNA, each PNA strand comprising: (i) from 2 to 50 nucleobase subunits and (ii) one or more gamma substituents. The PNA strands are complementary to at least a portion of at least some of the polynucleotide strands, and the molar ratio of PNA strands to polynucleotide strands being at least 1:1. Certain gamma substituents are capable of effecting attachment of a PNA strand to a cell. The invention also concerns construction of nanostructure platforms and vaccines and use of the inventive compositions in inhibiting disease states in mammals.
• cGAP-PNA MULTIVALENT PEPTIDE NUCLEIC ACID LIGAND DISPLAY
  申请人：THE USA, AS REPRESENTED BY THE SECRETARY, DEPART- MENT OF HEALTH AND HUMAN SERVICES

  公开号：US20170002355A1

  公开（公告）日：2017-01-05

  Described herein are compositions composed of peptide nucleic acid strands. In some aspects the peptide nucleic acid strands are complementary to at least a portion of another peptide nucleic acid strand that may have one or more gamma substituents, where the ratio of PNA strands is least 1:1. Certain gamma substituents are capable of effecting attachment of a PNA strand to a cell. The disclosure also concerns construction of nanostructure platforms and vaccines and use of the inventive compositions in inhibiting disease states in mammals.
• US9861702B2
  申请人：——

  公开号：US9861702B2

  公开（公告）日：2018-01-09